Prematurity and low weight at birth as new conditions predisposing to an increased cardiovascular risk

European Journal of Preventive Cardiology

Volumn 20, Issue 2, 2013, Pages 357-367

  Mercuro, Giuseppe ^a   Bassareo, Pier Paolo ^a   Flore, Giovanna ^a   Fanos, Vassilios ^a   Dentamaro, Ilaria ^b   Scicchitano, Pietro ^b   Laforgia, Nicola ^b   Ciccone, Marco Matteo ^b  

^a Policlinico Universitario   (Italy)

^b UNIVERSITY OF BARI   (Italy)

Author keywords

Birth weight; Cardiovascular risk; Follow up; Preterm; Prevention

Indexed keywords

CORTICOSTEROID; BIOLOGICAL MARKER;

BLOOD PRESSURE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CORTICOSTEROID THERAPY; DISEASE PREDISPOSITION; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; ENDOTHELIAL DYSFUNCTION; FETUS GROWTH; GESTATIONAL AGE; HUMAN; HYPERURICEMIA; LOW BIRTH WEIGHT; NEWBORN HYPOXIA; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PREMATURITY; PRIORITY JOURNAL; REVIEW; ADOLESCENT; ADULT; BIRTH WEIGHT; BLOOD; CARDIOVASCULAR DISEASE; FEMALE; KIDNEY; MALE; MIDDLE AGED; MORTALITY; NEWBORN; PATHOPHYSIOLOGY; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR; VASCULAR ENDOTHELIUM;

ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; ASPHYXIA NEONATORUM; BIOLOGICAL MARKERS; BIRTH WEIGHT; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; HYPERURICEMIA; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; INFANT, PREMATURE; KIDNEY; MALE; MIDDLE AGED; OBESITY; PREMATURE BIRTH; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; YOUNG ADULT;

EID: 84881537685     PISSN: 20474873     EISSN: 20474881     Source Type: Journal    
DOI: 10.1177/2047487312437058     Document Type: Review

References (100)

1. Goldenberg RL, Culhane JF, Iams JD, et al. Epidemiology and causes of preterm birth. Lancet 2008;371(9606):75-84.
2. Burke C and Morrison JJ. Perinatal factors and preterm delivery in an Irish obstetric population. J Perinat Med 2000;28(1):49-53.
3. Weismiller DG. Preterm labor. Am Fam Physician 1999;59(3):593-602.
4. Field DJ, Dorling JS, Manktelow BN, et al. Survival of extremely premature babies in a geographically defined population: prospective cohort study of 1994-9 compared with 2000-5. BMJ 2008;336(7655):1221-1223.
5. Fellman V, Hellstrom-Westas L, Norman M, et al. Oneyear survival of extremely preterm infants after active perinatal care in Sweden. JAMA 2009;301(21):2225-2233.
6. Swamy GK, Ostbye T and Skjaerven R. Association of preterm birth with long-term survival, reproduction, and next-generation preterm birth. JAMA 2008;299(12):1429-1436.
7. Silverman WA. Compassion or opportunism? Pediatrics 2004;113(2):402-403.
8. Dalziel SR, Parag V, Rodgers A, et al. Cardiovascular risk factors at age 30 following pre-term birth. Int J Epidemiol 2007;36(4):907-915.
9. Eriksson JG, Forsen T, Tuomilehto J, et al. Early growth and coronary heart disease in later life: longitudinal study. BMJ 2001;322(7292):949-953.
10. Chauhan SP, Magann EF, Velthius S, et al. Detection of fetal growth restriction in patients with chronic hypertension: is it feasible? J Matern Fetal Neonatal Med 2003;14(5):324-328.
11. Nardi O, Zureik M, Courbon D, et al. Preterm delivery of a first child and subsequent mothers' risk of ischaemic heart disease: a nested case-control study. Eur J Cardiovasc Prev Rehabil 2006;13(2):281-283.
12. Lawlor DA, Owen CG, Davies AA, et al. Sex differences in the association between birth weight and total cholesterol. A meta-analysis. Ann Epidemiol 2006;16(1):19-25.
13. Owen CG, Whincup PH, Odoki K, et al. Birth weight and blood cholesterol level: a study in adolescents and systematic review. Pediatrics 2003;111(5 Pt 1):1081-1089.
14. Huxley R, Owen CG, Whincup PH, et al. Birth weight and subsequent cholesterol levels: exploration of the 'fetal origins' hypothesis. JAMA 2004;292(22):2755-2774.
15. Celermajer DS, Sorensen KE, Gooch VM, et al. Noninvasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992;340(8828):1111-1115.
16. Adams MR and Celermajer DS. Detection of presymptomatic atherosclerosis: a current perspective. Clin Sci (Lond) 1999;97(5):615-624.
17. Leeson CP, Kattenhorn M, Morley R, et al. Impact of low birth weight and cardiovascular risk factors on endothelial function in early adult life. Circulation 2001;103(9):1264-1268.
18. Singhal A, Kattenhorn M, Cole TJ, et al. Preterm birth, vascular function, and risk factors for atherosclerosis. Lancet 2001;358(9288):1159-1160.
19. Bassareo PP, Fanos V, Puddu M, et al. Reduced brachial flow-mediated vasodilation in young adult ex extremely lowbirthweight preterm: a condition predictive of increased cardiovascular risk? J Matern Fetal Neonatal Med 2010;23(S3):121-124.
20. Norman M and Martin H. Preterm birth attenuates association between low birth weight and endothelial dysfunction. Circulation 2003;108(8):996-1001.
21. Yeboah J, Burke GL, Crouse JR, et al. Relationship between brachial flow-mediated dilation and carotid intima-media thickness in an elderly cohort: the Cardiovascular Health Study. Atheroscler 2008;197(2):840-845.
22. Vapaatalo H and Mervaala E. Clinically important factors influencing endothelial function. Med Sci Monit 2001;7(5):1075-1085.
23. Vida G, Sulyok E, Lakatos O, et al. Plasma levels of asymmetric dimethylarginine in premature neonates: its possible involvement in developmental programming of chronic diseases. Acta Paediatr 2009;98(3):437-441.
24. Boger RH, Vallance P and Cooke JP. Asymmetric dimethylarginine (ADMA): a key regulator of nitric oxide synthase. Atheroscler Suppl 2003;4(4):1-3.
25. Schulze F, Lenzen H, Hanefeld C, et al. Asymmetric dimethylarginine is an independent risk factor for coronary heart disease: results from the multicenter Coronary Artery Risk Determination investigating the Influence of ADMA Concentration (CARDIAC) study. Am Heart J 2006;152(3):493.e1-8.
26. Valkonen VP, Paiva H, Salonen JT, et al. Risk of acute coronary events and serum concentrations of asymmetrical dimethylarginine. Lancet 2001;358(9299):2127-2128.
27. Bassareo PP, Puddu M, Flore G, et al. Could ADMA levels in young adults born preterm predict an early endothelial dysfunction? Int J Cardiol 2011 [Epublication ahead of print].
28. Richir MC, Van Leeuwen PA, Van Den Berg A, et al. Plasma ADMA concentrations at birth and mechanical ventilation in preterm infants: a prospective pilot study. Pediatr Pulmonol 2008;43(12):1161-1166.
29. Hinchliffe SA, Lynch MR, Sargent PH, et al. The effect of intrauterine growth retardation on the development of renal nephrons. Br J Obstetr Gynaecol 1992;99(4):296-301.
30. Koeda Y, Nakamura M, Tanaka F, et al. Serum C-reactive protein levels and death and cardiovascular events in mild to moderate chronic kidney disease. Int Heart J. 2011;52(3):180-184.
31. Boger RH and Zoccali C. ADMA: a novel risk factor that explains excess cardiovascular event rate in patients with end-stage renal disease. Atheroscler Suppl 2003;4(4):23-28.
32. Rinat C, Becker-Cohen R, Nir A, et al. A comprehensive study of cardiovascular risk factors, cardiac function and vascular disease in children with chronic renal failure. Nephrol Dial Transplant 2010;25(3):785-793.
33. Tulassay T and Vasarhelyi B. Birth weight and renal function. Curr Opin Nephrol Hypertens 2002;11(3):347-352.
34. Keijzer-Veen MG, Dulger A, Dekker FW, et al. Very preterm birth is a risk factor for increased systolic blood pressure at a young adult age. Pediatr Nephrol 2010;25(3):509-516.
35. Kusano E. Mechanism by which chronic kidney disease causes cardiovascular disease and the measures to manage this phenomenon. Clin Exp Nephrol 2011;15(5):627-633.
36. Ritz E. Hypertension: the kidney is the culprit even in the absence of kidney disease. Kidney Intern 2007;71(5):371-372.
37. Martyn CN and Greenwald SE. Mechanisms in utero programming of blood pressure. In: Barker DJP (ed.) Fetal origins of cardiovascular and lung disease. New York, NY: Marcel Dekker, 2001, pp. 49-59.
38. Girerd X, Laurent S, Pannier B, et al. Arterial distensibility and left ventricular hypertrophy in patients with sustained essential hypertension. Am Heart J 1991;122(4 Pt 2):1210-1214.
39. Norman M. Low birth weight and the developing vascular tree: a systematic review. Acta Paediatr 2008;97(9):1165-1172.
40. Vehaskari VM, Stewart T, Lafont D, et al. Kidney angiotensin and angiotensin receptor expression in prenatally programmed hypertension. Am J Physiol Renal Physiol 2004;287(2):F262-F267.
41. Lackland DT, Egan BM, Syddall HE, et al. Associations between birth weight and antihypertensive medication in black and white medicaid recipients. Hypertension 2002;39(1):179-183.
42. Marks JF, Kay J, Baum J, et al. Uric acid levels in fullterm and low-birth-weight infants. J Pediatr 1968;73(4):609-611.
43. Franco MC, Christofalo DM, Sawaya AL, et al. Effects of low birth weight in 8- to 13-year-old children: implications in endothelial function and uric acid levels. Hypertension 2006;48(1):45-50.
44. Feig DI, Nakagawa T, Karumanchi SA, et al. Hypothesis: uric acid, nephron number, and the pathogenesis of essential hypertension. Kidney Int 2004;66(1):281-287.
45. Schuster E and Weppelmann B. Plasma urate measurements and fetal outcome in preeclampsia. Gynecol Ostet Invest 1981;12(3):162-167.
46. Sanchez-Lozada LG, Tapia E, Johnson RJ, et al. Glomerular hemodynamic changes associated with arteriolar lesions and tubulo-interstitial inflammation. Kidney Int Suppl 2003; (suppl 86):S9-S14.
47. Feig DI and Johnson RJ. Hyperuricemia in childhood essential hypertension. Hypertension 2003;42(3):247-252.
48. Black MJ, Briscoe TA, Constantinou M, et al. Is there an association between level of adult blood pressure and nephron number or surface area? Kidney Int 2004;65(2):582-588.
49. Skov K and Mulvany MJ. Structure of renal afferent arterioles in the pathogenesis of hypertension. Acta Physiol Scand 2004;181(4):397-405.
50. Nakagawa T, Tuttle KR, Short RA, et al. Fructoseinduced hyperuricemia as a causal mechanism for the epidemic of the metabolic syndrome. Nature Clinical Practice Nephrology 2006;1(2):80-86.
51. Simmons R. Perinatal programming of obesity. Semin Perinatol 2008;32(5):371-374.
52. Hirschler V, Bugna J, Roque M, et al. Does low birth weight predict obesity/overweight and metabolic syndrome in elementary school children? Arch Med Res 2008;39(8):796-802.
53. Rajaleid K, Janszky I and Hallqvist J. Small birth size, adult overweight, and risk of acute myocardial infraction. Epidemiology 2011;22(2):138-147.
54. Eriksson JG. The fetal origins hypothesis - 10 years on. BMJ 2005;330(7500):1096-1097.
55. Wei JN, Li HY, Sung FC, et al. Birth weight correlates differently with cardiovascular risk factors in youth. Obesity (Silver Spring) 2007;15(6):1609-1616.
56. Morgan AR, Thompson JM, Murphy R, et al. Obesity and diabetes genes are associated with being born small for gestational age: results from the Auckland Birthweight Collaborative study. BMC Med Genet 2010;11:125.
57. Eriksson JG, Forsen TJ, Kajantie E, et al. Childhood growth and hypertension in later life. Hypertension 2007;49(6):1415-1421.
58. Whincup PH, Kaye SJ, Owen CG, et al. Birth weight and risk of type 2 diabetes: a systematic review. JAMA 2008;300(24):2886-2897.
59. Pilgaard K, Færch K, Carstensen B, et al. Low birthweight and premature birth are both associated with type 2 diabetes in a random sample of middle-aged Danes. Diabetologia 2010;53(12):2526-2530.
60. Euser AM, Dekker FW and Hallan SI. Intrauterine growth restriction: no unifying risk factor for the metabolic syndrome in young adults. Eur J Cardiovasc Prev Rehabil 2010;17(3):314-320.
61. Rotteveel J, Van Weissenbruch MM, Twisk JW, et al. Infant and childhood growth patterns, insulin sensitivity, and blood pressure in prematurely born young adults. Pediatrics 2008;122(2):313-321.
62. American Academy of Pediatrics and Canadian Paediatric Society. Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants. Pediatrics 2002;109(2):330-338.
63. Brand PL, Van Lingen RA, Brus F, et al. Hypertrophic obstructive cardiomyopathy as a side effect of dexamethasone treatment for bronchopulmonary dysplasia. Acta Pediatr 1993;82(6-7):614-617.
64. Israel B, Sherman F and Guthrie R. Hypertrophic cardiomyopathy associated with dexamethasone therapy for chronic lung disease in preterm infants. Am J Perinatol 1993;10(4):307-310.
65. Nelson N and Nylander E. Neonatal ventricular hypertrophy without cardiac malformations: a retrospective evaluation of 17 infants. Prenatal and Neonatal Medicine 2001;6(5):318-322.
66. Lilien L, Lilien R and Setrakian S. Hemopericardium and cardiac tamponade as presenting findings of dexamethasone-induced hypertrophic cardiomyopathy complicated by transmural myocardial infarction. Pediatr Cardiol 2003;24(3):280-283.
67. Van Der Leij F, Reijngoud D, Sauer P, et al. Postnatal treatment with dexamethasone perturbs hepatic and cardiac energy metabolism and is associated with a sustained atherogenic plasma lipid profile in suckling rats. Pediatr Res 2003;61(2):165-170.
68. Di Somma S, Di Benedetto MP, Salvatore G, et al. Desmin-free cardiomyocytes and myocardial dysfunction in end stage heart failure. Eur J Heart Fail 2004;6(4):389-398.
69. Whitehurst Jr RM, Zhang M, Bhattacharjee A, et al. Dexamethasone-induced hypertrophy in rat neonatal cardiac myocytes involves an elevated L-type Ca (2+) current. J Mol Cell Cardiol 1999;31(8):1551-1558.
70. Gopinath B, Trent R and Yu B. Molecular characterisation of neonatal cardiac hypertrophy and its regression. Cardiol Young 2004;14(5):498-505.
71. Bal MP, De Vries WB, Steendijk P, et al. Histopathological changes of the heart after neonatal dexamethasone treatment: studies in 4-, 8-, and 50-weekold rats. Pediatr Res 2009;66(1):74-79.
72. Karemaker R, Karemaker JM, Kavelaars A, et al. Effects of neonatal dexamethasone treatment on the cardiovascular stress response of children at school age. Pediatrics 2008;122(5):978-987.
73. Bazett HC. An analysis of the time-relations of the electrocardiagrams. Heart 1920;7:353-370.
74. Zabel M, Portnoy S and Franz MR. Electrocardiographic indexes of dispersion of ventricular repolarization: an isolated heart validation study. J Am Coll Cardiol 1995;25(3):746-752.
75. Bassareo PP, Fanos V, Puddu M, et al. Significant QT interval prolongation and long QT iQTQT in young adult ex preterm newborns with extremely low birth weight. J Matern Fetal Neonatal Med 2011;24(9):1115-1118.
76. Marjamaa A, Salomaa V, Newton-Cheh C, et al. High prevalence of four long QT syndrome founder mutations in the Finnish population. Ann Med 2009;41(3):234-240.
77. Rodriguez MM, Gomez AH, Abitbol CL, et al. Histomorphometric analysis of postnatal glomerulogenesis in extremely preterm infants. Pediatr Dev Pathol 2004;7(1):17-25.
78. Malik M and Batchvarov VN. Measurement, interpretation and clinical potential of QT dispersion. J Am Coll Cardiol 2000;36(6):1749-1766.
79. Kurosu M, Ando Y, Akimoto T, et al. Factors related to the QT prolongation in chronic renal failure. Nippon Jinzo Gakkai Shi 1999;41(2):70-76.
80. Nakamura S, Ogata C, Aihara N, et al. QTc dispersion in haemodialysis patients with cardiac complications. Nephrology (Carlton) 2005;10(2):113-118.
81. Jackman WM, Friday KJ, Anderson JL, et al. The long QT syndromes: a critical review, new clinical observations and unifying hypothesis. Prog Cardiovasc Dis 1988;31(2):115-172.
82. Witchel HJ and Hancox JC. Familial and acquired long QT syndrome and the cardiac rapid delayed rectifier potassium current. Clin Exp Pharmacol Physiol 2000;27(10):753-766.
83. Volpe JJ. The encephalopathy of prematurity - brain injury and impaired brain development inextricably intertwined. Semin Pediatr Neurol 2009;16(4):167-178.
84. Khechinashvili G and Asplund K. Electrocardiographic changes in patients with acute stroke: a systematic review. Cerebrovasc Dis 2002;14(2):67-76.
85. Zipes DP, Camm AJ, Borggrefe M, et al.; American College of Cardiology/American Heart Association Task Force; European Society of Cardiology Committee for Practice Guidelines; European Heart Rhythm Association; Heart Rhythm Society. ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 2006;114(10):385-484.
86. Haverkamp W, Breithardt G, Camm AJ, et al. The potential for QT prolongation and pro-arrhythmia by non-antiarrhythmic drugs: clinical and regulatory implications. Report on a policy conference of the European Society of Cardiology. Eur Heart J 2000;21(15):1216-1231.
87. Ciccone MM, Scicchitano P, Zito A, et al. Different functional cardiac characteristics observed in term/preterm neonates by echocardiography and tissue doppler imaging. Early Hum Dev 2011;87(8):555-558.
88. Ranjit MS. Cardiac abnormalities in birth asphyxia. Indian J Pediatr 2000;67(S3):S26-S29.
89. Donnelly WH, Bucciarelli RL and Nelson RM. Ischemic papillary muscle necrosis in stressed newborn infants. J Pediatr 1980;96(2):295-300.
90. Barberi I, Calabro MP, Cordaro S, et al. Myocardial ischaemia in neonates with perinatal asphyxia. Electrocardiographic, echocardiographic and enzymatic correlations. Eur J Pediatr 1999;158(9):742-747.
91. Correale M, Nunno L, Ieva R, et al. Troponin in newborns and pediatric patients. Cardiovasc Hematol Agents Med Chem 2009;7(4):270-278.
92. Crispi F, Bijnens B, Figueras F, et al. Fetal growth restriction results in remodelled and less efficient hearts in children. Circulation 2010;121(22):2427-2436.
93. McEniery CM, Bolton CE, Fawke J, et al. Cardiovascular consequences of extreme prematurity: the EPICure study. J Hypertens 2011;29(7):1367-1373.
94. Willemsen RH, De Kort SW, Van Der Kaay DC, et al. Independent effects of prematurity on metabolic and cardiovascular risk factors in short small-forgestational-age children. J Clin Endocrinol Metab 2008;93(2):452-458.
95. Al Salmi I, Hoy WE, Kondalsamy-Chennakesavan S, et al. Disorders of glucose regulation in adults and birth weight: results from the Australian Diabetes, Obesity and Lifestyle (AUSDIAB) Study. Diabetes Care 2008;31(1):159-164.
96. Gamborg M, Byberg L, Rasmussen F, et al; NordNet Study Group. Birth weight and systolic blood pressure in adolescence and adulthood: meta-regression analysis of sex- and age-specific results from 20 Nordic studies. Am J Epidemiol 2007;166(6):634-645.
97. Martin H, Lindblad B, Norman M. Endothelial function in newborn infants is related to folate levels and birth weight. Pediatrics 2007;119(6):1152-1158.
98. Forsen T, Eriksson J, Tuomilehto J, et al. The fetal and childhood growth of persons who develop type 2 diabetes. Ann Intern Med 2000;133(3):176-182.
99. Rich-Edwards JW, Stampfer MJ, Manson JE, et al. Birth weight and risk of cardiovascular disease in a cohort of women followed up since 1976. BMJ 1997;315(7105):396-400.
100. Lithell HO, McKeigue PM, Berglund L, et al. Relation of size at birth to non-insulin dependent diabetes and insulin concentrations in men aged 50-60 years. BMJ 1996;312(7028):406-410.